SCM
Silverarc Capital Management’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Buy |
539,587
+9,587
| +2% | +$52.4K | 0.54% | 38 |
|
|
2025
Q1 | $3.33M | Sell |
530,000
-204,234
| -28% | -$1.28M | 0.68% | 39 |
|
|
2024
Q4 | $3.03M | Buy |
734,234
+251,659
| +52% | +$1.04M | 0.66% | 39 |
|
|
2024
Q3 | $1.61M | Sell |
482,575
-361,660
| -43% | -$1.21M | 0.36% | 51 |
|
|
2024
Q2 | $2.52M | Hold |
844,235
| – | – | 0.59% | 44 |
|
|
2024
Q1 | $2.91M | Sell |
844,235
-19,648
| -2% | -$67.8K | 0.81% | 37 |
|
|
2023
Q4 | $1.16M | Sell |
863,883
-63,532
| -7% | -$85.1K | 0.34% | 55 |
|
|
2023
Q3 | $2.02M | Buy |
927,415
+41,491
| +5% | +$90.5K | 0.61% | 37 |
|
|
2023
Q2 | $2.12M | Hold |
885,924
| – | – | 0.66% | 40 |
|
|
2023
Q1 | $1.64M | Buy |
885,924
+118,293
| +15% | +$219K | 0.68% | 43 |
|
|
2022
Q4 | $1.48M | Sell |
767,631
-171,634
| -18% | -$331K | 0.42% | 54 |
|
|
2022
Q3 | $1.45M | Buy |
+939,265
| New | +$1.45M | 0.49% | 48 |
|